Eli Lilly and Nvidia are launching a joint artificial intelligence lab in South San Francisco with 70 people to speed up drug ...

Jan 23 (Reuters) - Novo Nordisk's Wegovy pill was prescribed ‌18,410 ​times in the U.S. in ‌the first full week after its ...

The VanEck Pharmaceutical ETF (NYSEARCA:PPH) has surged 26% over the past year, driven almost entirely by the weight-loss ...

Novo Nordisk A/S is rated a Buy with solid long-term prospects, and the stock appears undervalued. Learn more about NVO stock ...

"I was just enrolling the kids into summer camp," one mother told IndyStar. Lifelong Ransburg YMCA members react to the news ...

Regeneron Pharmaceuticals, Inc. nears a key earnings report after a strong JPM Healthcare update. Click here to find out why ...

In the latest trading session, Eli Lilly (LLY) closed at $1,064.29, marking a -2.12% move from the previous day. This change lagged the S&P 500's 0.03% gain on the day. Elsewhere, the Dow saw a ...

Eli Lilly's valuation has been driven higher by investor excitement around GLP-1 drugs, leaving other drugmakers languishing.

This biotech has candidates in late-stage clinical development.

Prior to this, Shroff led Apple’s India marketing across segments, and earlier headed product marketing. He was also SVP at ...

CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.

GLP-1 giant Eli Lilly has once again taken to the medium of short film to deliver an important message about obesity. | GLP-1 ...